Go back to News
NEWS
GA_P advises on Grifols’ €1.300m bond issue
29 January, 2025
Gómez-Acebo & Pombo has advised the underwriters of the 1,300 million euros bonds issued by Grifols, maturing in May 2030.
The net proceeds of the transaction, which was subject to New York law, will be used mainly to repay existing debt and to fully repay the outstanding revolving loans, extending the credit facility until May 2027.
The team consisted of: Álvaro Sáinz, Irene Medina de Alba and Patricia González de Huelbes from the Banking and Finance team in Madrid and London respectively.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
6 days ago 
PUBLICATION
2 days ago
Borderline products and the precedence of medicinal product legislation
The application of the rule of precedence requires, firstly, that a given product falls within the legal definition of a medicinal product, whether it is a medicinal product by function or by presentation, and secondly, that there are doubts as to whether it also falls within the legal concept of other types of products (food supplements, cosmetics, etc.).
2 days ago 
PUBLICATION
09 Oct, 2025
Payment service providers’ rectification of unauthorised or incorrectly executed payment transactions: user obligations
The Court of Justice of the European Union (Fourth Chamber), in its judgment of 1 August 2025, case C-665/23, IL v. Veracash SAS, concludes that a payer is deprived of the right to reimbursement of the amount of an unauthorised transaction if he or she delayed in notifying his or her payment service provider of the unauthorised payment transaction, even though he or she did so within 13 months from the debit date. This interpretation of the Payment Services Directive is applicable in Spain (Art. 43 RDL 19/2018) and appears to be retained in the future Regulation on payment services.
09 Oct, 2025
PUBLICATION
25 Sep, 2025
Pharma & Healthcare No. 45
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
25 Sep, 2025
PUBLICATION
30 Jul, 2025
Absolute prohibitions on pharmacy advertising are contrary to EU law
In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.
30 Jul, 2025
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
02 Jul, 2025
PUBLICATION
16 Apr, 2025
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
16 Apr, 2025
PUBLICATION
01 Apr, 2025
Professional Purchasers of Non-Performing Credit: the new Law is ahead
The content of the Directive on credit servicers and credit purchasers, only of non-performing credit (NPC), has been transposed into Spanish law more than a year late. The Bill introduces the administrative regime for credit servicers and amends, among others, the Consumer Credit Act and the Real Estate Credit Agreements Act.
01 Apr, 2025
PUBLICATION
27 Mar, 2025
The notion of ‘pharmacological action’ in the legal concept of medicinal product
A look at the judgment of the Court of Justice in Case C-589/23, Cassella-med and MCM Klosterfrau, ECLI:EU:C:2025:173.
27 Mar, 2025
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
10 Mar, 2025